|Dr. Matthias Dose
Professor of Psychiatry, University of Munich, Germany.
|Prof.Dr.med. Matthias Dose has received his MD at the Technical University of Munich/Germany (TUM). He has been a research fellow and senior researcher at the Max-Planck-Institute of Psychiatry/Munich 1980-1989. Having successfully completed his work as medical director of kbo-Klinikum Taufkirchen (Vils) from 1993 -2014 he is currently working as a senior consultant for Autism-Spectrum Disorders (ASD) and Huntingtons Disease (HD) for kbo (Kommunalunternehmen Kliniken des Bezirk Oberbayern) and is a member of the Faculty of Medicine at TUM. His research has included clinical studies on psychotropic effects of anticonvulsants, movement disorders, relapse prevention in schizophrenia, HD and ASD. Based on this research and fellowship training he is a member of the scientific advisory boards of Deutsche Huntington-Hilfe e.V. and Autismus Deutschland and acknowledged supervisor for PTSD of the Bayerische LandesÃ¤rztekammer. He has been serving as an expert Reviewer for journals like Pharmacopsychiatry, Journal of Neurology, Journal of Neuropathology and Neurobiology, and Journal of Public Health. He has authored and co-authored more than 200 research articles and 5 books. He is a member of Deutsche Gesellschaft faur Psychiatrie, Psychotherapie und Nervenheilkunde/DGPPN, of the European College of Neuropsychopharmacology/ECNP and of the European Huntington Disease Network/EHDN.|
|Autism spectrum disorders,Psychiatric symptoms in Huntingtons Disease,Psychiatric side effects of antipsychotics and on a broader range, Schizophrenia and bipolar affective disorders.|
All Published work is licensed under a Creative Commons Attribution 4.0 International License
Copyright © 2017 All rights reserved. iMedPub Last revised : October 20, 2017